Susan Critchlow, Ph.D. is a Senior Director in the Oncology group at AstraZeneca based in Cambridge, UK. A member of AstraZeneca’s Oncology Discovery leadership team, Susan leads the UK bioscience group delivering key data to support taking novel Oncology drugs into the clinic. Since joining AstraZeneca, Susan has delivered across the drug discovery pipeline from Target Identification to Candidate Drug nomination and supported drug projects in clinical development. Susan has broad cancer biology knowledge and has worked in the DNA damage response, tumour drivers, tumour metabolism and immune-oncology fields. Her group play a key role in selecting and developing new precision medicines, drug combination opportunities and addressing drug resistance mechanisms.